Topic

Aetna (CVS Health)

A collection of 1351 issues

How to Get Joenja (leniolisib) Covered by Aetna CVS Health in Pennsylvania: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Joenja (leniolisib) Covered by Aetna CVS Health in Pennsylvania Fastest path to approval: Submit prior authorization with confirmed APDS genetic testing (pathogenic PIK3CD or PIK3R1 variant), specialist documentation, and prior therapy history. If denied, file internal appeal within 180 days, then pursue Pennsylvania's external review
5 min read

Get Pyrukynd (Mitapivat) Covered by Aetna CVS Health in Michigan: Prior Authorization Forms, Appeal Process, and Alternative Options

Quick Answer: Getting Pyrukynd (Mitapivat) Covered by Aetna CVS Health in Michigan Pyrukynd requires prior authorization from Aetna CVS Health. Most denials stem from incomplete genetic testing documentation or missing hematology specialist oversight. First step: Have your hematologist submit a prior authorization request with confirmed PKLR gene variants, baseline hemoglobin
6 min read

Work With Your Doctor to Get iLink® Corneal Cross-Linking Covered by Aetna CVS Health in Florida

Answer Box: Getting iLink® Covered by Aetna CVS Health in Florida Eligibility: Aetna CVS Health covers FDA-approved iLink® corneal cross-linking for progressive keratoconus when you meet specific criteria: documented disease progression over 3-6 months, minimum 400-micron corneal thickness, and treatment at an in-network facility. Fastest path: Work with your ophthalmologist
7 min read

How to Get Voxzogo (Vosoritide) Covered by Aetna CVS Health in Ohio: Complete 2025 Guide with Forms and Appeals

Answer Box: Getting Voxzogo (Vosoritide) Covered by Aetna CVS Health in Ohio Aetna CVS Health covers Voxzogo for pediatric achondroplasia patients with open growth plates, requiring prior authorization from a pediatric endocrinologist, geneticist, or neurologist. The fastest path to approval: (1) Confirm FGFR3 mutation or clinical achondroplasia diagnosis with X-ray
6 min read